Stevanato Group S.p.A. (STVN) Stock Analysis
Healthcare · Medical Instruments & Supplies
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two... Read more
TrendMatrix rates Stevanato Group S.p.A. (STVN) as Hold with moderate confidence. The stock trades at $14.18 with +52.6% upside to the $21.64 price target. Overall score: 5.6/10 across 10 analysis dimensions. Reward/risk ratio: 16.4:1.
Passes 3/5 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.
Investment Thesis
Fundamentals
Frequently Asked Questions
TrendMatrix rates Stevanato Group S.p.A. (STVN) as Hold with moderate confidence. Score 5.6/10.
Take-profit target: $21.64 (+52.6% upside). Reward/risk ratio: 16.4:1. Stop-loss: $13.72.
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Negative momentum; Below 200-day MA.
Stevanato Group S.p.A. trades at a P/E of 24.7 (forward 17.1). TrendMatrix value score: 7.4/10. Verdict: Hold.
17 analysts cover STVN with a consensus score of 4.2/5. Average price target: $25.
What does Stevanato Group S.p.A. do?Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide...
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.